Innoprot provides products and technologies for multiplexing cell-based assays in drug discovery and development. With a proprietary technology for GPCR screening, Innoprot is able to identify the compounds with the highest effectiveness but avoiding the undesired side effects. Innoprot also acts as a C.R.O. providing screening services focused on GPCRs, Fibrosis and Neurodegenerative diseases like Alzheimer's Disease, Parkinson's Disease or ALS.
Innoprot
Parque Tecnologico Bizkaia
Edificio 502, Primera Planta
Derio, Pais Vasco 48160
Spain